Development code · Peptide
LY3537031
LY3537031 is a development code for Brenipatide, developed by Eli Lilly and Company.
- Status
- Phase 3 for Alcohol use disorder
- Mechanism
- Glucagon-like peptide 1 receptor Agonist
- Developer
- Eli Lilly and Company
Programs
- Brenipatide for Alcohol use disorderPhase 3Active
- Brenipatide for Bipolar disorderPhase 2Active
- Brenipatide for SchizophreniaPhase 2Active
- Brenipatide for Opioid use disorderPhase 2Active
- Brenipatide for Tobacco use disorderPhase 2Active
- Brenipatide for Major depressive disorderPhase 3Active
Also known as
- brenipatide
- LY-3537031
- 2408921-49-1